Josh Wolfe - 04 Feb 2026 Form 4 Insider Report for Eikon Therapeutics, Inc. (EIKN)

Reporting relationship
Director, 10%+ Owner
Issuer ticker
EIKN
Reported as of
04 Feb 2026
Net transaction value
+$4,999,968
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Feb 2026, 18:27:59 UTC
Prior SEC filing
20 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Benjamin Thorner, Attorney in Fact

Key filing fact

Josh Wolfe filed Form 4 for Eikon Therapeutics, Inc. (EIKN) on 06 Feb 2026.

Key facts

  • This page summarizes Josh Wolfe's Form 4 filing for Eikon Therapeutics, Inc. (EIKN).
  • 15 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 06 Feb 2026, 18:27.

Change

  • Previous filing in this sequence was filed on 20 Jun 2023.
  • Current net transaction value: +$4,999,968.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001830001 Primary reporting owner

Wolfe Josh

Relationship
Director, 10%+ Owner
Address
C/O EIKON THERAPEUTICS, 230 HARRIET TUBMAN WAY, MILLBRAE
Signature
/s/ Benjamin Thorner, Attorney in Fact
Signature date
06 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EIKN transaction

Common Stock

Purchase

Transaction value
$2,499,984
Shares
+138,888
Change %
Price
$18.00
Shares after
138,888
Date
04 Feb 2026
Ownership
See footnote
Footnotes
F1
EIKN transaction

Common Stock

Purchase

Transaction value
$2,499,984
Shares
+138,888
Change %
Price
$18.00
Shares after
138,888
Date
04 Feb 2026
Ownership
See footnote
Footnotes
F2
EIKN transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+2,387,705
Change %
Price
Shares after
2,387,705
Date
06 Feb 2026
Ownership
See footnote
Footnotes
F3, F4, F5
EIKN transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,151,540
Change %
+829%
Price
Shares after
1,290,428
Date
06 Feb 2026
Ownership
See footnote
Footnotes
F1, F4, F6, F7
EIKN transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+2,155,765
Change %
+1552%
Price
Shares after
2,294,653
Date
06 Feb 2026
Ownership
See footnote
Footnotes
F2, F6, F7, F8, F9, F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EIKN transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-10,000,000
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
1,340,878
Exercise price
Footnotes
F3, F5
EIKN transaction Derivative

Series A-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-7,807,026
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
1,046,827
Exercise price
Footnotes
F4, F5
EIKN transaction Derivative

Series A-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-2,502,252
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
335,521
Exercise price
Footnotes
F1, F4
EIKN transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-796,380
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
106,785
Exercise price
Footnotes
F1, F6
EIKN transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-530,920
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
71,190
Exercise price
Footnotes
F2, F6
EIKN transaction Derivative

Series B-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-5,289,322
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
709,234
Exercise price
Footnotes
F1, F7
EIKN transaction Derivative

Series B-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-3,526,215
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
472,822
Exercise price
Footnotes
F2, F7
EIKN transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value
Shares
-303,360
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
40,677
Exercise price
Footnotes
F2, F8
EIKN transaction Derivative

Series C-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-1,450,614
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
194,510
Exercise price
Footnotes
F2, F9
EIKN transaction Derivative

Series D Preferred Stock

Conversion of derivative security

Transaction value
Shares
-10,266,152
Change %
-100%
Price
Shares after
0
Date
06 Feb 2026
Ownership
See footnote
Underlying class
Common Stock
Underlying amount
1,376,566
Exercise price
Footnotes
F2, F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and the Reporting Person (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.

Footnote F2

These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.

Footnote F3

The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date.

Footnote F4

The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

Footnote F5

These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein.

Footnote F6

The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

Footnote F7

The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

Footnote F8

The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

Footnote F9

The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

Footnote F10

The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .